It is also used as part of neuroprotective protocols for patients concerned about long-term cognitive health
Cereus in the Presence of 13 C 6 -Cereulide Aliquots (19.8 mL) of LB medium (including 0.2% glucose) were mixed with an ethanolic solution (0.2 mL) of 13 C 6 -cereulide (10 g/mL) and, then, inoculated with the B
Clinical substantiation remains to be provided in suitable safety and efficacy trials
No other authors have any conflicts of interest
Management of associated conditions is essential: Diabetes control : Pioglitazone and GLP-1 receptor agonists (such as liraglutide or semaglutide) show hepatic benefits in clinical trials, but their use for NASH is off-label in the UK and should be initiated and monitored by specialists after careful riskbenefit discussion
Finally, remember that the most reliable half-life and stability data are always those published in peer-reviewed pharmacokinetic studies for the specific peptide, formulation, and species of interest